Steward Partners Investment Advisory, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 162 filers reported holding ANTARES PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$16,000
+6.7%
4,000
-1.9%
0.00%
Q4 2021$15,000
-11.8%
4,077
-10.4%
0.00%
Q3 2021$17,0000.0%4,552
+13.8%
0.00%
Q2 2021$17,000
-100.0%
4,000
-79.8%
0.00%
-100.0%
Q1 2021$81,378,000
+508512.5%
19,800
+395.0%
0.00%
Q4 2020$16,000
+14.3%
4,000
-23.1%
0.00%
Q3 2020$14,000
+133.3%
5,200
+120.5%
0.00%
Q2 2020$6,000
+100.0%
2,358
+73.6%
0.00%
Q1 2020$3,0000.0%1,358
+69.8%
0.00%
Q4 2019$3,000
+200.0%
800
+45.5%
0.00%
Q3 2019$1,0005500.00%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders